ImmuCell CorporationICCCNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank79
Studio
Year-over-Year Change

Free cash flow yield

Latest
0.00%
↑ 100% vs avg
Percentile
P79
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-10.10%
Historical baseline
PeriodValueYoY Change
20250.00%+100.0%
2024-0.26%+98.5%
2023-16.76%-43.4%
2022-11.68%-328.9%
2021-2.72%+57.6%
2020-6.42%-94.8%
2019-3.30%+47.0%
2018-6.22%+83.7%
2017-38.12%-145.1%
2016-15.55%-